Evidence map›Paper›PMID 32128167›Full record

ArticleClinical case reports2020

Effectiveness of clozapine, oxcarbazepine and rivastigmine combination in a bipolar disorder patient with initial cerebral atrophy.

Paolo Morana, Federico Mucci, Stefano Baroni, Alessandra Della Vecchia, Armando Piccinni, Benedetto Morana, Donatella Marazziti

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Conserved gene signatures shared amongFrontiers in molecular biosciences · 2023
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Paolo MoranaCasa di cura Morana Marsala Italy.
Federico MucciDipartimento di Medicina Clinica e Sperimentale Section of Psychiatry University of Pisa Italy.ORCID https://orcid.org/0000-0002-9746-8237
Stefano BaroniDipartimento di Medicina Clinica e Sperimentale Section of Psychiatry University of Pisa Italy.ORCID https://orcid.org/0000-0001-7688-5069
Alessandra Della VecchiaDipartimento di Medicina Clinica e Sperimentale Section of Psychiatry University of Pisa Italy.
Armando PiccinniBrain Research Foundation (BRF) Lucca Italy.ORCID https://orcid.org/0000-0002-2724-2830
Benedetto MoranaCasa di cura Morana Marsala Italy.
Donatella MarazzitiDipartimento di Medicina Clinica e Sperimentale Section of Psychiatry University of Pisa Italy.ORCID https://orcid.org/0000-0002-4021-5829
University of Pisa · ITCasa di Cura Columbus · ITBrain Research Foundation · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper reports the case of a 46-year-old woman suffering from bipolar disorder of type I with mixed features with initial fronto-temporal atrophy. Although considered treatment-resistant to conventional strategies, she successfully responded to a combination of rivastigmine, clozapine, and oxcarbazepine.

Indexed as

bipolar disordersclozapinedepressionfronto‐temporal atrophymixed featuresoxcarbazepinerivastigmine

Identifiers

PMID32128167
PMCPMC7044366
OpenAlexW2999297664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.